PharmChem, Inc.
PCHM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6,085 | $6,012 | $5,837 | $6,220 |
| % Growth | 1.2% | 3% | -6.2% | – |
| Cost of Goods Sold | $2,208 | $2,108 | $2,091 | $2,330 |
| Gross Profit | $3,877 | $3,904 | $3,746 | $3,891 |
| % Margin | 63.7% | 64.9% | 64.2% | 62.5% |
| R&D Expenses | $0 | $2 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,215 | $2,931 | $2,665 | $2,346 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,215 | $2,931 | $2,665 | $2,346 |
| Operating Income | $1,663 | $973 | $1,082 | $1,545 |
| % Margin | 27.3% | 16.2% | 18.5% | 24.8% |
| Other Income/Exp. Net | $78 | $80 | $25 | $129 |
| Pre-Tax Income | $1,741 | $1,054 | $1,106 | $1,673 |
| Tax Expense | $360 | $209 | $236 | -$179 |
| Net Income | $1,381 | $845 | $870 | $1,852 |
| % Margin | 22.7% | 14.1% | 14.9% | 29.8% |
| EPS | 0.3 | 0.17 | 0.17 | 0.32 |
| % Growth | 76.5% | 0% | -46.9% | – |
| EPS Diluted | 0.3 | 0.17 | 0.16 | 0.28 |
| Weighted Avg Shares Out | 4,645 | 4,971 | 5,072 | 5,767 |
| Weighted Avg Shares Out Dil | 4,645 | 4,971 | 5,340 | 6,624 |
| Supplemental Information | – | – | – | – |
| Interest Income | $77 | $80 | $25 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1,741 | $1,054 | $1,106 | $1,673 |
| % Margin | 28.6% | 17.5% | 19% | 26.9% |